SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001658551-15-000002
Filing Date
2015-11-20
Accepted
2015-11-20 15:30:17
Documents
1
Effectiveness Date
2015-11-20
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8256
  Complete submission text file 0001658551-15-000002.txt   9306
Mailing Address 210 BROADWAY #201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY #201 CAMBRIDGE MA 02139 617-571-8872
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-251392 | Film No.: 151246483